Navigation Links
Dominion Diagnostics Introduces CARD™: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
Date:6/15/2010

NORTH KINGSTOWN, R.I., June 15 /PRNewswire/ -- At the forefront of the ongoing effort to enhance addiction treatment outcomes, one leading Rhode Island Company has announced the next-generation clinical laboratory diagnostics tool designed to assist clinicians.  

Dominion Diagnostics (Dominion), a privately-held clinical urine drug testing laboratory, today announced the release of its new Comprehensive Analysis of Reported Drugs (CARD)™ results, a unique clinical laboratory reporting service that provides clinicians with accurate testing results and analytical feedback to augment the assessment and monitoring of an individual's drug use upon admission and throughout the course of addiction treatment.

Dominion developed its CARD™ reporting service to create a highly personalized clinical report by correlating an individual's prescribed medication use and self-reported drug misuse with its state-of-the-art diagnostic testing.

CARD™ utilizes laboratory results from validated quantitative urine drug testing profiles for commonly abused illicit and prescription drugs and/or their metabolites, as well as biological markers and commercial adulterant screening (i.e., creatinine, specific gravity, pH, and oxidants) to ensure specimen validity.   CARD™ employs a supplied list of prescribed treatment-related medications and self-reported non-prescribed drug misuse, along with documented pharmaceutical and pharmacokinetic references backed by Dominion's expert Clinical Services team of pharmacists.  

Dominion's CARD™ results provide data to support and measure a treatment program's ability to reduce morbidity in substance abuse, improve retention in treatment, and promote the use of evidence-based practice for individuals suffering from addiction and mental health disorders, in line with ongoing initiatives supported by the Substance Abuse and Mental Health Services Agency (SAMHSA).

"CARD™ is a new service that will assist clinicians in tailoring addiction treatment services to each individual, thus improving  treatment  retention and outcomes by providing a more complete picture of their clients' treatment progress," said Dominion's Vice President of Addiction Services, Mary Hauser, MA.  "It is the first objective laboratory reporting tool of its kind."

For treatment programs, CARD™ provides a mechanism for reporting summary data that reflects client's medication compliance and treatment progress on a quarterly or annual basis. This data can be used by treatment programs to report outcomes to a wide variety of private and governmental funding sources.    

ABOUT DOMINION DIAGNOSTICS

Dominion Diagnostics is a premier provider of comprehensive clinical quantitative urine drug testing, medication monitoring and support services nationwide. For over 13 years, Dominion has provided services to thousands of clients in a variety of medical specialties, including Addiction Treatment, Behavioral Health, Pain Medicine, Primary Care, and Hospital Systems.  Dominion is supported by a world-class team that shares a commitment to clinical and operational excellence.  For more information about Dominion, please visit www.dominiondiagnostics.com.

Media Contact:

Julie K. Lenahan, MBA, Director of Marketing, 401/667-0876, jlenahan@dominiondiagnostics.com


'/>"/>
SOURCE Dominion Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
3. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
4. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
7. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
8. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
9. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
10. Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
11. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward joins ... other leading institutions in announcing the launch of the Leadership Circle , ... animals are raised for food. , Founding members of the Leadership Circle also ...
Breaking Medicine News(10 mins):